CCM

Consonance Capital Management Portfolio holdings

AUM $7.28M
1-Year Est. Return 42.86%
This Quarter Est. Return
1 Year Est. Return
-42.86%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$23.7M
AUM Growth
-$35.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
8
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$8.46M
2
+$5.7M
3
+$5.08M
4
CMPX icon
Compass Therapeutics
CMPX
+$4.99M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$1.52M

Sector Composition

1 Healthcare 99.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRZN icon
1
Surrozen
SRZN
$114M
$10.5M 44.25%
233,167
SLN
2
Silence Therapeutics
SLN
$305M
$7.52M 31.7%
634,270
-19,838
CMPX icon
3
Compass Therapeutics
CMPX
$722M
$4.22M 17.79%
1,603,789
-1,896,211
UTHR icon
4
United Therapeutics
UTHR
$19.5B
$706K 2.98%
2,998
-21,565
GMED icon
5
Globus Medical
GMED
$8.01B
$303K 1.28%
5,405
-101,619
TNDM icon
6
Tandem Diabetes Care
TNDM
$996M
$254K 1.07%
4,294
-143,033
SRZNW icon
7
Surrozen Inc Warrant
SRZNW
$39.5K
$223K 0.94%
1,165,832
MLTX icon
8
MoonLake Immunotherapeutics
MLTX
$573M
– –
-137,000